The Mark Foundation for Cancer Research
New York City, New Yorkthemarkfoundation.org
Overview
The Mark Foundation for Cancer Research is a non-profit organization that accelerates research to transform the prevention, diagnosis, and treatment of cancer through grants and early-stage venture investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hyku Biosciences | Nov 2024 | Seed | Co-investor |
| Accent Therapeutics | Jan 2024 | Series C | Co-investor |
| Hyku Biosciences | Sep 2023 | Seed | Co-investor |
| TORL BioTherapeutics | Apr 2023 | Series B | - |
| Vicinitas | Jul 2022 | Series A | Co-investor |
Key People
Janice Lin
Portfolio Manager, Research Investments
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
